News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AstraZeneca PLC (AZN) Settles U.S. Pricing Lawsuit for $103 Million


6/21/2010 7:15:21 AM

Reuters -- AstraZeneca PLC (AZN.L) has agreed to pay $103 million to settle U.S. litigation involving claims the drugmaker inflated prices for its Zoladex cancer drug and Pulmicort Respules asthma medicine.

Read at Elsevier
Read at Business Week
Read at Reuters
Read at Wall Street Journal
Read at Business Week

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES